Dyne Therapeutics, Inc. · NASDAQ:DYN
Friedl-Naderer Johanna sold 1,085 Dyne Therapeutics, Inc. shares (Form 4)
Traded Sep 4 to Sep 8, 2026 · Filed Sep 8, 2026
From Sep 4 to Sep 8, 2026, Friedl-Naderer Johanna (Chief Commercial Officer) sold 1,085 Dyne Therapeutics, Inc. shares at an average US$23.42 for US$25,408 under a trading plan, leaving 152,897 shares. Filed Sep 8, 2026 (Form 4).
- Sold
- 1,085 shares
- Price
- US$23.42 average (US$18.88 to US$24.35)
- Value
- US$25,408
- Holding after
- 152,897 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Common Stock | Sale | 900 | US$24.35 | 153,082 | Direct |
| Sep 8, 2026 | Common Stock | Sale | 185 | US$18.88 | 152,897 | Direct |
Source
Related
- Dyne Therapeutics, Inc.
- Friedl-Naderer Johanna
- Dyne Therapeutics, Inc. shareholders
- Form 4 · Friedl-Naderer Johanna · Aug 17, 2026
- Form 4 · Friedl-Naderer Johanna · Jun 17, 2026
- Form 4 · Friedl-Naderer Johanna · May 14, 2026
- Form 4 · Kerr Douglas · Oct 22, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Rhodes Jason P · Aug 17, 2026